HRI’s Dr Renuka Shanmugalingam awarded at SOMANZ
HRI’s Dr Renuka Shanmugalingam recently received the SOMANZ Andrew Phippard Memorial Award for best scientific research oral presentation.
HRI raises awareness on World Thrombosis Day
To celebrate World Thrombosis Day, HRI’s Thrombosis and Haematology Research Groups did their part to raise awareness of thrombosis – a leading factor in heart attacks and stroke.
Dr Anna Waterhouse presents keynote lecture at inaugural Nature Conference
Dr Anna Waterhouse delivered the prestigious keynote lecture ‘Biomimicry in blood-contacting medical devices’, presenting the problem of thrombosis, fibrosis and microbe biofouling with blood-contacting medical devices, highlighting that relying on drugs to solve medical device problems results in increased risks of adverse events for patients.
HRI UK funds cutting-edge microscopes
The generosity of HRI UK supporters has enabled the purchase of two cutting-edge microscopes that will help speed our cardiovascular disease research to the next breakthrough.
Congratulations to PhD Student, Jessica Maclean
HRI’s PhD Student Jessica Maclean won Best Oral Presentation at the joint scientific meeting of the Australian Vascular Biology Society (AVBS), the Australia/New Zealand Microcirculation Society (ANZMS) and the Asia/Australia Vascular Biology Meeting (AAVBM).
HRI’s Manisha Patel wins Best Poster Award
Congratulations to HRI’s Research Assistant Manisha Patil for winning Best Poster Award by a postgraduate student at the 20th Scientific Meeting of the Australian & New Zealand Microcirculation Society (ANZMS).
HRI Supports Cutting-edge Heart Research
Heart Research Institute is helping to bring together world-leading scientists to solve some of the most pressing issues affecting the hearts of people around the world.
Esteemed HRI Researcher Wins Blackburn Medal
Heart Research Institute scientist David Celermajer has been awarded the inaugural Ruthven Blackburn Medal for his distinguished lifetime contribution to Clinical Research.
HRI’s stroke medication breakthrough is featured on Channel 9 News
HRI spoke to Channel 9 News Health Reporter Gabriella Rogers about how a breakthrough anti-clotting drug is poised to enter Phase 2 clinical trials to improve the quality of life for thousands of stroke sufferers.